Serum ALT, glucose, cholesterol and triglyceride were all lower in G3 group (twice a week G-CSF) than the NAFLD group (Supplementary Table 2) (Figure 2B). The gene discussed is CSF3; the disease is metabolic dysfunction-associated steatotic liver disease.